Prudential Financial’s Dyne Therapeutics DYN Stock Holding History

Prudential Financial’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$499K	Buy	22,480 +1,905	+9%	+$35.4K	﹤0.01%	1914
2026 Q1	$373K	Buy	+20,575	New	+$355K	﹤0.01%	1959
2025 Q4	–	Sell	-13,210	Closed	-$167K	–	2277
2025 Q3	$167K	Buy	13,210 +1,505	+13%	+$17.2K	﹤0.01%	2231
2025 Q2	$111K	Buy	+11,705	New	+$129K	﹤0.01%	2278
2025 Q1	–	Sell	-145,510	Closed	-$3.43M	–	2313
2024 Q4	$3.43M	Sell	145,510 -110,400	-43%	-$3.27M	﹤0.01%	1026
2024 Q3	$9.19M	Buy	255,910 +2,865	+1%	+$114K	0.01%	718
2024 Q2	$8.93M	Buy	253,045 +107,885	+74%	+$3.13M	0.01%	683
2024 Q1	$4.12M	Buy	+145,160	New	+$3.28M	0.01%	1033

Other funds holding DYN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Prudential Financial's DYN Position: Q2 2026 in Review

Prudential Financial increased its Dyne Therapeutics (DYN) stake by 9.3% in Q2 2026, buying an estimated $35.4K and bringing the position to 22,480 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

Prudential Financial first reported a position in DYN in Q1 2024 and has held it in 8 quarters since. The position peaked at $9.19M in Q3 2024. 155 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

Prudential Financial held 22,480 shares of Dyne Therapeutics worth $499K as of Q2 2026.
Prudential Financial bought 1,905 Dyne Therapeutics shares in Q2 2026, an estimated $35.4K.
Dyne Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1914 holding.
Prudential Financial first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 8 quarters since.
Prudential Financial's Dyne Therapeutics position peaked at $9.19M in Q3 2024.
155 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.